Landscapes / Companies
Beijing Konruns Pharmaceutical Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 4 in all
Trials
5 active
11 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | 30 Dec 2026Phase 3 trial completes | |||
| Next date | 30 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Esophageal Squamous Cell Carcinoma, Ewing Sarcoma and 1 more | ||||
| Open drug page | |||||
— |
Phase 2 | Nov 2029Phase 2 trial completes | |||
| Next date | Nov 2029 · Phase 2 trial completes | ||||
| Also tested for | Advanced Solid Tumors Cancer, HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer | ||||
| Open drug page | |||||
About
- No active trial
- CX1003, Jincaopian
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021